Nicholas Conrad Smith insider trades

Open-market stock purchases and sales by Nicholas Conrad Smith, PRESIDENT AND CFO at Alto Neuroscience, Inc, from SEC Form 4 filings since Feb 6, 2024.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +45%.

Recent trades

DateStockTradeValue
Oct 2, 2026ANRO Alto Neuroscience, IncBought (not open market)—
Sep 30, 2026ANRO Alto Neuroscience, IncSold$597K
Sep 30, 2026ANRO Alto Neuroscience, IncSold$23.8K
Sep 30, 2026ANRO Alto Neuroscience, IncBought (not open market)—
Sep 29, 2026ANRO Alto Neuroscience, IncSold$2.9M
Sep 29, 2026ANRO Alto Neuroscience, IncBought (not open market)—
Sep 29, 2026ANRO Alto Neuroscience, IncBought (not open market)—
Mar 1, 2026ANRO Alto Neuroscience, IncSold (not open market)$55.3K
Feb 11, 2026ANRO Alto Neuroscience, IncBought (not open market)—

Companies traded

  • ANRO Alto Neuroscience, Inc: 3 buys, 3 sales, last Oct 2, 2026

Get free alerts when Nicholas Conrad Smith files a new trade →